Welcome to our dedicated page for Streamline Health Solutions In news (Ticker: STRM), a resource for investors and traders seeking the latest updates and insights on Streamline Health Solutions In stock.
Streamline Health Solutions Inc (STRM) provides technology-driven revenue cycle optimization for healthcare organizations through AI-enhanced platforms and enterprise analytics. This news hub offers investors and industry professionals verified updates on strategic developments impacting the company's financial and operational performance.
Access timely announcements including earnings reports, partnership agreements, product innovations, and leadership changes. Our curated collection focuses on events influencing STRM's market position in healthcare IT, such as SaaS platform enhancements, regulatory compliance updates, and health system client acquisitions.
Key coverage areas span financial results, technology deployments, executive appointments, and industry recognition. All content undergoes strict editorial review to ensure accuracy and relevance for stakeholders tracking revenue cycle management trends.
Bookmark this page for streamlined access to STRM's latest developments in coding automation, clinical documentation improvement, and healthcare data integration solutions. Check regularly for updates reflecting the company's progress in reducing revenue leakage for hospital networks nationwide.
Streamline Health Solutions (NASDAQ: STRM) reported its financial results for the third quarter and first nine months of fiscal 2020, concluding on October 31, 2020. Total revenues for Q3 were $2.6 million, down from $3.5 million a year earlier, despite a 48% increase in SaaS revenue. For the first nine months, revenues reached $8.4 million, a decrease from $9.2 million in 2019. The company posted a net income of $1.5 million for this period, attributed to discontinued operations. Adjusted EBITDA for Q3 saw a loss of $0.7 million, while improvements in costs were noted post-ECM business sale.
Streamline Health Solutions (NASDAQ: STRM) will announce its third quarter 2020 financial performance on December 8, 2020, after market close. A conference call to discuss results is scheduled for December 9, 2020, at 9:00 AM ET, accessible via webcast or by phone at 877-269-7756. A replay will be available from December 9 to December 16.
Streamline Health Solutions (NASDAQ: STRM) has expanded its partnership with Allscripts Healthcare Solutions (NASDAQ: MDRX) to include eValuator and Clinical Documentation Integrity (CDI) solutions, enhancing their reseller agreement. This initiative aims to help healthcare providers optimize their revenue cycle, addressing issues like coding errors and compliance risks before billing. The expanded relationship, validated by Allscripts' Go To Market committee, positions Streamline Health's technology as a vital resource for improving financial performance in the healthcare sector.
Streamline Health Solutions announced its financial results for the second quarter and first half of fiscal 2020, ending July 31. The company reported total revenues of $2.9 million for Q2, a 16% increase year-over-year. SaaS revenue grew 46% to $254,000. However, the company faced a net loss of ($1.1 million) for Q2, compared to a ($0.6 million) loss in Q2 2019. For the first half, total revenue reached $5.7 million with $2.5 million in net income, greatly influenced by a $4.7 million gain from discontinued operations. Adjusted EBITDA recorded a loss of ($1.0 million) for the first six months.
Streamline Health Solutions (NASDAQ: STRM) has announced a new contract with a major health system in the Mid-Atlantic, set to utilize its eValuator™ Revenue Integrity Program. This cloud-based solution aims to enhance revenue integrity by identifying coding issues before billing, consequently mitigating revenue leakage and compliance risks. The partnership signifies a growing trend in healthcare towards pre-bill technology, aiming to optimize financial performance amidst evolving payment models. CEO Tee Green highlights the significance of supporting quality care delivery through this collaboration.
Streamline Health Solutions (NASDAQ: STRM) announced plans to release its second quarter 2020 financial results on September 9, 2020, after market close. The results will be discussed in a conference call on September 10, 2020, at 9:00 AM ET, accessible via a live webcast or by phone. A replay will be available from September 10, 2020, to September 17, 2020. Streamline Health specializes in revenue integrity solutions for healthcare providers through its eValuator™ program, aiming to enhance revenue compliance and quality of care.
Streamline Health Solutions (NASDAQ: STRM) has secured a contract with a large academic medical center in the Midwest to implement its eValuator™ Revenue Integrity Program. This technology assists in pre- and post-bill coding analysis to enhance revenue integrity for both inpatient and outpatient services. By identifying coding issues before submission, it aims to reduce revenue leakage and compliance risks. The contract reflects a growing trend among healthcare providers to adopt pre-bill technology to improve financial outcomes amid complex payment guidelines.
Streamline Health Solutions (NASDAQ: STRM) announced a contract with an academic teaching hospital in the Mid Atlantic, utilizing its eValuator system for inpatient billing. This cloud-based automated coding technology aims to enhance revenue integrity by identifying coding issues pre-bill, minimizing revenue leakage, and ensuring compliance. Streamline Health's initiative aligns with the growing demand for such solutions in healthcare, emphasizing the need for accurate coding amidst challenging times. CEO Tee Green highlighted the importance of accurate coding for financial performance and quality care delivery.
Streamline Health Solutions (NASDAQ: STRM) reported Q1 2020 revenue of $2.8 million, down from $3.2 million in Q1 2019, primarily affected by COVID-19. The loss from continuing operations was ($1.0 million), compared to ($0.6 million) the previous year. Adjusted EBITDA also declined to ($0.6 million) from ($0.262 million). However, recurring revenue rose to 75% of total revenue. A significant $4.7 million gain from the sale of the ECM business contributed to a net income of $3.7 million. Management remains optimistic about future growth despite current challenges.
Streamline Health Solutions (NASDAQ: STRM) announced its upcoming financial performance release for the first quarter of 2020, which ended on April 30. The report will be disclosed on June 10, 2020, after market close. A conference call to review these results is scheduled for June 11, 2020, at 9:00 AM ET, accessible via a live webcast or by phone. A replay of the call will be available from June 11 until June 18, along with an online replay for six months on the company’s website.
FAQ
What is the current stock price of Streamline Health Solutions In (STRM)?
What is the market cap of Streamline Health Solutions In (STRM)?
